MDS patient elderly or frail (age ≥80, ECOG ≥3, life expectancy <2 years, multiple comorb...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-MDS-FRAILTY-AGE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-MDS-HR DIS-MDS-LR |
| Sources | SRC-ESMO-MDS-2021 SRC-NCCN-AML-2025 |
Red Flag Origin
| Definition | MDS patient elderly or frail (age ≥80, ECOG ≥3, life expectancy <2 years, multiple comorbidities) where best supportive care or low-intensity HMA is preferred over alloHCT or intensive disease modification |
|---|---|
| Clinical direction | de-escalate |
| Category | frailty-age |
| Shifts algorithm | ALGO-MDS-HR-1L |
Trigger Logic
{
"any_of": [
{
"comparator": ">=",
"finding": "age_years",
"threshold": 80
},
{
"finding": "mds_frail_unfit",
"value": true
},
{
"all_of": [
{
"comparator": ">=",
"finding": "ecog_performance_status",
"threshold": 3
},
{
"comparator": ">=",
"finding": "comorbidities_count",
"threshold": 3
}
]
}
],
"type": "composite"
}
Notes
Triggers de-escalation: in MDS-HR, opt for HMA or best-supportive-care pathway over alloHCT (which has high TRM in this group); in MDS-LR, emphasize transfusion strategy + iron chelation + symptom management. STUB — requires clinical co-lead signoff.
Used By
Algorithms
ALGO-MDS-HR-1L- ALGO-MDS-HR-1LALGO-MDS-HR-2L- ALGO-MDS-HR-2LALGO-MDS-LR-1L- ALGO-MDS-LR-1LALGO-MDS-LR-2L- ALGO-MDS-LR-2L
Indications
IND-MDS-HR-1L-AZA- IND-MDS-HR-1L-AZAIND-MDS-HR-1L-VEN-AZA- IND-MDS-HR-1L-VEN-AZAIND-MDS-HR-ALLOHCT- IND-MDS-HR-ALLOHCTIND-MDS-LR-2L-IMETELSTAT- IND-MDS-LR-2L-IMETELSTAT